BCG January 10, 2025
As competitive intensity and speed of innovation increase across disease states, the ability to systematically identify and act on market signals quickly is becoming a critical source of competitive advantage in the biopharma and biotech industries.
However, in our work with clients, we have found that brand teams can often miss, ignore, or downplay common signals that their market is being disrupted and their competitive position weakened. The good news is that brand teams can learn to identify—and address—the warning signs.
Today’s Crowded Therapeutic Market
Executives are under enormous pressure to deliver sustained...
Today's Sponsors
Today's Sponsor